首页> 外文OA文献 >Phase I study on the safety, pharmacokinetic profile, and efficacy of the combination of TSU-68, an oral antiangiogenic agent, and S-1 in patients with advanced hepatocellular carcinoma

【2h】

Phase I study on the safety, pharmacokinetic profile, and efficacy of the combination of TSU-68, an oral antiangiogenic agent, and S-1 in patients with advanced hepatocellular carcinoma

机译：一期研究：口服抗血管生成剂TSU-68和S-1联合治疗晚期肝细胞癌的安全性，药代动力学和疗效

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者

展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Phase I study on the safety, pharmacokinetic profile, and efficacy of the combination of TSU-68, an oral antiangiogenic agent, and S-1 in patients with advanced hepatocellular carcinoma. [J] . Masafumi Ikeda, Shuichiro Shiina, Kohei Nakachi, Investigational new drugs. . 2014,第5期

机译：I期研究了口服抗血管生成剂TSU-68和S-1联合治疗晚期肝细胞癌的安全性，药代动力学和疗效。
2. A phase I/II trial of the oral antiangiogenic agent TSU-68 in patients with advanced hepatocellular carcinoma. [J] . Kanai F, Yoshida H, Tateishi R, Cancer chemotherapy and pharmacology. . 2011,第2期

机译：口服抗血管生成剂TSU-68在晚期肝细胞癌患者中的I / II期试验。
3. A phase I/II trial of the oral antiangiogenic agent TSU-68 in patients with advanced hepatocellular carcinoma [J] . Fumihiko Kanai, Haruhiko Yoshida, Ryosuke Tateishi, Cancer Chemotherapy and Pharmacology . 2011,第2期

机译：口服抗血管生成剂TSU-68在晚期肝细胞癌患者的I / II期试验
4. Kinetic Textural Biomarker for Predicting Survival of Patients with Advanced Hepatocellular Carcinoma After Antiangiogenic Therapy by Use of Baseline First-Pass Perfusion CT [C] . Sang Ho Lee, Koichi Hayano, Dushyant V. Sahani, International conference on medical image computing and computer-assisted intervention;International workshop on abdominal imaging: computational and clinical applications . 2014

机译：动力学纹理生物标志物通过基线首过灌注CT预测抗血管生成治疗后晚期肝细胞癌患者的生存率
5. Therapeutic Effect of Adenovirus- and alpha-fetoprotein Promoter-mediated tBid and Chemotherapeutic Agents in Combination on Orthotopic Hepatocellular Carcinoma in Mice. [D] . Ma, Shihong. 2010

机译：腺病毒和甲胎蛋白启动子介导的tBid和化学治疗剂联合治疗对小鼠原位肝细胞癌的治疗作用。
6. Phase I study on the safety pharmacokinetic profile and efficacy of the combination of TSU-68 an oral antiangiogenic agent and S-1 in patients with advanced hepatocellular carcinoma [O] . Masafumi Ikeda, Shuichiro Shiina, Kohei Nakachi, -1

机译：一期研究：口服抗血管生成剂TSU-68和S-1联合治疗晚期肝细胞癌的安全性药代动力学和疗效
7. Phase I/II study of the pharmacokinetics, safety and efficacy of S-1 in patients with advanced hepatocellular carcinoma [O] . Junji Furuse, Takuji Okusaka, Shuichi Kaneko, 2010

机译：肝癌患者患者的药代动力学，S-1的药代动力学，安全性和疗效的阶段I / II研究

Phase I study on the safety, pharmacokinetic profile, and efficacy of the combination of TSU-68, an oral antiangiogenic agent, and S-1 in patients with advanced hepatocellular carcinoma

著录项

引文网络

相似文献

相关主题

期刊订阅